Acer Therapeutics Inc. (ACER) [Rocket]

In millions, except per share items	Dec-31-22	Dec-05-22	Dec-31-21	Dec-05-21	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17
	10-K	8-K	10-K	8-K	10-K	10-K	10-K	10-K
Net income	-26.2	-26.2	-15.4	-15.4	-22.9	-29.4	-21.3	-14.2
Depreciation and amortization [+]					0.1	0.1	0.0	0.0
Depreciation					0.1	0.1	0.0	0.0
Asset impairment charges					0.1
Stock-based compensation					2.2	2.6	1.3	0.4
Change in working capital [+]	0.3		-0.4		3.1	-2.8	3.4	-0.6
Other current assets					0.0	0.3	-0.2	-0.3
Accounts payable					1.1	-0.5	0.9	-0.3
Accrued expenses					1.8		2.6	0.1
Other	0.3		-0.4		0.1	-2.6
Other operating activities	-4.3		15.7		0.4	0.0	0.0	0.2
Cash from operations	-30.3		-0.1		-17.0	-29.5	-16.6	-14.1

Capital expenditures	0.2		0.1		0.0	-0.2	-0.1	-0.1
Purchases of property and equipment	0.2		0.1		0.0	-0.2	-0.1	-0.1
Other cash from investing	-0.3		-0.1					1.0
Cash from investing	-0.2		-0.1		0.0	-0.2	-0.1	1.0

Issuance of common stock, net	8.9		3.1		10.2		42.6	21.5
Option exercises						0.1	0.1
Financing costs	0.7							-0.1
Other cash from financing	11.9		4.0		0.6	0.2	0.2	5.4
Cash from financing	20.0		7.1		10.7	0.1	42.7	26.9

Free cash flow	-30.1		-0.1		-17.0	-29.7	-16.7	-14.2
Per share (diluted)	($1.91)		($0.01)		($1.53)	($2.94)	($1.95)	($3.83)

Cash paid for interest	0.1